SCHEMBL19620589

SCHEMBL19620589

NC1=C(OSCc2ccccc2)C(=O)C(c2ccc3ccccc3c2)O1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADK P55263 3/20 0.39
GSK3B P49841 2/20 0.39
POLB P06746 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPSR1 Q6W5P4 2/20 0.33
HTT P42858 1/20 0.33
CYP19A1 P11511 1/20 0.32
GRIA3 P42263 1/20 0.32
GRIA4 P48058 1/20 0.32
ELANE P08246 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
ALOX5 P09917 1/20 0.31
SCN9A Q15858 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620603 0.86 POLB (0.50) ADKPOLBKDM4EMAPTCYP1A2
SCHEMBL19620593 0.85 KDM4E (0.36) ADKPOLBKDM4EMAPTCYP1A2
SCHEMBL19620492 0.85 KDM4E (0.36) ADKPOLBKDM4EMAPTCYP1A2
SCHEMBL19620456 0.84 TOP2A (0.36) POLBKDM4EMAPTELANESLC6A4
SCHEMBL19620614 0.84 SLC6A2 (0.36) ADKGSK3BPOLBKDM4EMAPT
SCHEMBL19620501 0.84 MAPT (0.41) ADKPOLBKDM4EMAPTCYP3A4
SCHEMBL19620675 0.83 MAPT (0.42) ADKPOLBKDM4EMAPTNPSR1
SCHEMBL19620542 0.83 POLB (0.42) ADKGSK3BPOLBKDM4EMAPT
SCHEMBL19620522 0.83 KDM4E (0.42) ADKPOLBKDM4EMAPTHTT
SCHEMBL19620598 0.83 NPSR1 (0.44) GSK3BPOLBKDM4EMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3345596-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2021-01-20 EP disclosed
EP-3345596-A2 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2018-07-11 EP disclosed
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed